Vita Life Sciences Limited (VLS.AX)
AUD 1.75
(-3.58%)
AUD 1.75
(-3.58%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 74.16 Million AUD | 10.88% |
| 2022 | 66.88 Million AUD | 17.14% |
| 2021 | 57.1 Million AUD | 22.85% |
| 2020 | 46.48 Million AUD | 9.49% |
| 2019 | 42.45 Million AUD | 3.16% |
| 2018 | 41.15 Million AUD | 9.04% |
| 2017 | 37.73 Million AUD | -0.32% |
| 2016 | 37.85 Million AUD | -1.88% |
| 2015 | 38.58 Million AUD | 5.48% |
| 2014 | 36.58 Million AUD | 3.3% |
| 2013 | 35.41 Million AUD | 17.29% |
| 2012 | 30.19 Million AUD | 24.41% |
| 2011 | 24.26 Million AUD | 20.19% |
| 2010 | 20.19 Million AUD | 18.66% |
| 2009 | 17.01 Million AUD | 18.36% |
| 2008 | 14.37 Million AUD | 21.12% |
| 2007 | 11.86 Million AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 39.45 Million AUD | 0.0% |
| 2023 Q2 | 34.69 Million AUD | 0.0% |
| 2023 Q4 | 39.46 Million AUD | 0.0% |
| 2023 FY | 74.16 Million AUD | 10.88% |
| 2022 Q2 | 32.73 Million AUD | 0.0% |
| 2022 Q4 | 34.15 Million AUD | 0.0% |
| 2022 FY | 66.88 Million AUD | 17.14% |
| 2021 Q4 | 31.37 Million AUD | 0.0% |
| 2021 FY | 57.1 Million AUD | 22.85% |
| 2021 Q2 | 25.72 Million AUD | 0.0% |
| 2020 Q2 | 22.01 Million AUD | 0.0% |
| 2020 Q4 | 24.46 Million AUD | 0.0% |
| 2020 FY | 46.48 Million AUD | 9.49% |
| 2019 FY | 42.45 Million AUD | 3.16% |
| 2019 Q4 | 22.08 Million AUD | 0.0% |
| 2019 Q2 | 20.36 Million AUD | 0.0% |
| 2018 Q2 | 20.07 Million AUD | 95.17% |
| 2018 Q1 | 10.28 Million AUD | -47.36% |
| 2018 Q4 | 21.07 Million AUD | 0.0% |
| 2018 FY | 41.15 Million AUD | 9.04% |
| 2017 Q4 | 19.54 Million AUD | 0.0% |
| 2017 Q1 | 9.43 Million AUD | -52.17% |
| 2017 FY | 37.73 Million AUD | -0.32% |
| 2017 Q2 | 17.66 Million AUD | 87.19% |
| 2016 Q2 | 18.09 Million AUD | 91.15% |
| 2016 Q1 | 9.46 Million AUD | -53.56% |
| 2016 FY | 37.85 Million AUD | -1.88% |
| 2016 Q4 | 19.72 Million AUD | 0.0% |
| 2015 Q4 | 20.38 Million AUD | 111.28% |
| 2015 FY | 38.58 Million AUD | 5.48% |
| 2015 Q2 | 18.2 Million AUD | 88.72% |
| 2015 Q1 | 9.64 Million AUD | -48.8% |
| 2015 Q3 | 9.64 Million AUD | -47.01% |
| 2014 Q3 | 9.14 Million AUD | -48.45% |
| 2014 Q2 | 17.73 Million AUD | 93.97% |
| 2014 Q1 | 9.14 Million AUD | -50.1% |
| 2014 FY | 36.58 Million AUD | 3.3% |
| 2014 Q4 | 18.84 Million AUD | 106.03% |
| 2013 Q1 | 8.85 Million AUD | 0.0% |
| 2013 Q4 | 18.32 Million AUD | 107.03% |
| 2013 Q3 | 8.85 Million AUD | -48.18% |
| 2013 Q2 | 17.08 Million AUD | 92.97% |
| 2013 FY | 35.41 Million AUD | 17.29% |
| 2012 Q1 | 7.54 Million AUD | 0.0% |
| 2012 Q2 | 7.54 Million AUD | 0.0% |
| 2012 Q3 | 7.54 Million AUD | 0.0% |
| 2012 Q4 | 8.85 Million AUD | 17.29% |
| 2012 FY | 30.19 Million AUD | 24.41% |
| 2011 Q2 | 6.06 Million AUD | 0.0% |
| 2011 Q4 | 7.54 Million AUD | 24.41% |
| 2011 FY | 24.26 Million AUD | 20.19% |
| 2011 Q1 | 6.06 Million AUD | 0.0% |
| 2011 Q3 | 6.06 Million AUD | 0.0% |
| 2010 FY | 20.19 Million AUD | 18.66% |
| 2010 Q4 | 6.06 Million AUD | 20.19% |
| 2010 Q3 | 5.04 Million AUD | 0.0% |
| 2010 Q2 | 5.04 Million AUD | 0.0% |
| 2010 Q1 | 5.04 Million AUD | 0.0% |
| 2009 Q2 | 4.25 Million AUD | 0.0% |
| 2009 FY | 17.01 Million AUD | 18.36% |
| 2009 Q4 | 5.04 Million AUD | 18.66% |
| 2009 Q3 | 4.25 Million AUD | 0.0% |
| 2009 Q1 | 4.25 Million AUD | 0.0% |
| 2008 Q2 | 3.58 Million AUD | 0.0% |
| 2008 Q4 | 4.25 Million AUD | 18.52% |
| 2008 Q1 | 3.58 Million AUD | 0.0% |
| 2008 FY | 14.37 Million AUD | 21.12% |
| 2008 Q3 | 3.58 Million AUD | 0.0% |
| 2007 Q4 | 3.58 Million AUD | 20.95% |
| 2007 FY | 11.86 Million AUD | 0.0% |
| 2007 Q3 | 2.96 Million AUD | 0.0% |
| 2007 Q1 | 2.96 Million AUD | 0.0% |
| 2007 Q2 | 2.96 Million AUD | 0.0% |
| 2006 Q4 | 2.96 Million AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Althea Group Holdings Limited | 29.4 Million AUD | -152.24% |
| Cann Group Limited | 15.37 Million AUD | -382.411% |
| ECS Botanics Holdings Ltd | 20.03 Million AUD | -270.243% |
| Ecofibre Limited | 27.98 Million AUD | -165.012% |
| Elixinol Wellness Limited | 8.26 Million AUD | -796.856% |
| Hygrovest Limited | 260 Thousand AUD | -28423.462% |
| IDT Australia Limited | 13.22 Million AUD | -460.721% |
| Invion Limited | 3.69 Million AUD | -1907.468% |
| Little Green Pharma Ltd | 19.56 Million AUD | -278.994% |
| Live Verdure Ltd | 1.93 Million AUD | -3730.602% |
| Medical Developments International Limited | 33.14 Million AUD | -123.72% |
| Vitura Health Limited | 123.87 Million AUD | 40.13% |